ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,131.57
-0.19%
Dow Jones
38,586.08
-0.01%
Gold vs US Dollar
2,323.52
-0.41%
Brent Oil
82.965
1.02%
Bitcoin
65,549.00
-1.64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Relmada Therapeutics Inc (RLMD)

  7. Relmada Therapeutics Inc (RLMD) News

Relmada Therapeutics (RLMD)

Relmada Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RLMD
DateTimeSourceHeadlineSymbolCompany
30/05/202402:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
30/05/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
30/05/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
30/05/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
30/05/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
30/05/202402:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
08/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLMDRelmada Therapeutics Inc
19/03/202411:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:RLMDRelmada Therapeutics Inc
20/02/202422:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
14/02/202413:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RLMDRelmada Therapeutics Inc
31/01/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
31/01/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
31/01/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
11/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
04/01/202413:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
03/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
19/12/202322:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
08/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLMDRelmada Therapeutics Inc
08/11/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
11/10/202314:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
10/10/202322:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
04/10/202313:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
20/09/202321:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
06/09/202314:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
10/08/202321:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLMD

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
BT.A
Bt
LSE
EEE
Empire Metals
LSE
PANR
Pantheon Resources
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
THG
Thg
LSE
POS
Plexus
LSE
LBE
Longboat Energy
LSE
SDRY
Superdry
LSE
SOLG
Solgold
LSE
BIRD
Blackbird
LSE
ARCM
Arc Minerals
LSE
GOLD
LSE
KEFI
Kefi Gold And Copper
LSE
ENET
Ethernity Networks
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved